CoChat
Sign Up
Cited by 45

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

PKC downregulation upon rapamycin treatment attenuates mitochondrial disease

Martin-Perez, Miguel, Grillo, Anthony S., Ito, Takashi K., Valente, Anthony S., Han, Jeehae, Entwisle, Samuel W., Huang, Heather Z., Kim, Dayae, Yajima, Masanao, Kaeberlein, Matt, Villén, Judit·2020·Nature Metabolism
DOI 10.1038/s42255-020-00319-xPMC PMC8017771

Published version of a preprint

Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42255-020-00319-x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 42

  1. Rich, P. Chemiosmotic coupling: the cost of living. Nature 421, 583 (2003). · DOI
  2. Darin, N., Oldfors, A., Moslemi, A. R., Holme, E. & Tulinius, M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann. Neurol. 49, 377–383 (2001). · DOI
  3. Quintana, A., Kruse, S. E., Kapur, R. P., Sanz, E. & Palmiter, R. D. Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome. Proc. Natl Acad. Sci. USA 107, 10996–11001 (2010). · DOI
  4. Johnson, S. C. et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 342, 1524–1528 (2013). · DOI · Paper page
  5. Ising, C. et al. Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. EMBO Mol. Med. 7, 275–287 (2015). · DOI
  6. Khan, N. A. et al. mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression. Cell Metab. 26, 419–428.e5 (2017). · DOI
  7. Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122–1128 (2004). · DOI
  8. Sarbassov, D. D. et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159–168 (2006). · DOI · Paper page
  9. Lamming, D. W. et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638–1643 (2012). · DOI · Paper page
  10. Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296–1302 (2004). · DOI · Paper page
  11. Guertin, D. A. et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCɑ, but not S6K1. Dev. Cell. 11, 859–871 (2006). · DOI
  12. Gould, C. M. & Newton, A. C. The life and death of protein kinase C. Curr. Drug Targets 9, 614–625 (2008). · DOI
  13. Wang, Y. et al. Sequential posttranslational modifications regulate PKC degradation. Mol. Biol. Cell 27, 410–420 (2016). · DOI
  14. Ikenoue, T. et al. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signaling. EMBO J. 27, 1919–1931 (2008). · DOI
  15. Moon, J.-S. et al. mTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep. 12, 102–115 (2015). · DOI
  16. Savaskan, N. E., Bräuer, A. U. & Nitsch, R. Molecular cloning and expression regulation of PRG-3, a new member of the plasticity-related gene family. Eur. J. Neurosci. 19, 212–220 (2004). · DOI
  17. Shibuya, N. et al. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid. Redox Signal. 11, 703–714 (2009). · DOI
  18. Wesseling, H., Elgersma, Y. & Bahn, S. A brain proteomic investigation of rapamycin effects in the Tsc1+/− mouse model. Mol. Autism 8, 41 (2017). · DOI
  19. Peretti, D. et al. RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration. Nature 518, 236–239 (2015). · DOI
  20. Zhu, X., Bührer, C. & Wellmann, S. Cold-inducible proteins CIRP and RBM3, a unique couple with activities far beyond the cold. Cell. Mol. Life Sci. 73, 3839–3859 (2016). · DOI
  21. Wu, R. et al. A large-scale method to measure absolute protein phosphorylation stoichiometries. Nat. Methods 8, 677–683 (2011). · DOI
  22. Niemi, N. M. et al. Pptc7 is an essential phosphatase for promoting mammalian mitochondrial metabolism and biogenesis. Nat. Commun. 10, 3197 (2019). · DOI
  23. Hijazi, M. et al. Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring. Nat. Biotechnol. 38, 493–502 (2020). · DOI
  24. Ochoa, D. et al. An atlas of human kinase regulation. Mol. Syst. Biol. 12, 888 (2016). · DOI
  25. Zhou, X., Yang, W. & Li, J. Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-κB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-ɑ production in lipopolysaccharide-stimulated rat peritoneal macrophages. J. Biol. Chem. 281, 31337–31347 (2006). · DOI
  26. Lieu, Q. et al. Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca2+-dependent PKC/p38MAPK/NF-κB pathway. J. Neuroinflammation 16, 10 (2019).
  27. Leitges, M. et al. Immunodeficiency in protein kinase Cβ-deficient mice. Science 273, 788–791 (1996). · DOI
  28. Jope, R. S., Yuskaitis, C. J. & Beurel, E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 32, 577–595 (2007). · DOI · Paper page
  29. Mochly-Rose, D., Das, K. & Grimes, K. V. Protein kinase C, an elusive therapeutic target? Nat. Rev. Drug Discov. 11, 937–957 (2012). · DOI
  30. Aiello, L. P. et al. Oral protein kinase C β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the protein kinase C β inhibitor-diabetic retinopathy study and the protein kinase C β inhibitor-diabetic retinopathy study 2. Retina 31, 2084–2094 (2011). · DOI
  31. Jin, Z., Wei, W., Yang, M., Du, Y. & Wan, Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metab. 20, 483–498 (2014). · DOI · Paper page
  32. Lamming, D. W. et al. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan. Aging Cell 13, 911–917 (2014). · DOI · Paper page
  33. Fang, Y. et al. Effects of rapamycin on growth hormone receptor knockout mice. Proc. Natl Acad. Sci. USA 115, E1495–E1503 (2018).
  34. Sage-Schwaede, A. et al. Exploring mTOR inhibition as treatment for mitochondrial disease. Ann. Clin. Transl. Neurol. 6, 1877–1881 (2019). · DOI
  35. Johnson, S. C. et al. mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases. Kidney Int. 95, 455–466 (2019). · DOI
  36. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008). · DOI · Paper page
  37. Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016). · DOI · Paper page
  38. Cox, J. & Mann, M. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinform. 13, S12 (2012). · DOI
  39. Calvo, S. E., Clauser, K. R. & Mootha, V. K. MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins. Nucleic Acids Res. 44, D1251–D1257 (2016). · DOI · Paper page
  40. Eden, E. et al. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinform. 10, 48 (2009). · DOI · Paper page
  41. Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512–D520 (2015). · DOI · Paper page
  42. Schwartz, D. & Gygi, S. P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 23, 1391–1398 (2005). · DOI

Cited by

Sorted by citations

See all 45

Metadata

Authors
Martin-Perez, M., Grillo, A. S., Ito, T. K., Valente, A. S., Han, J., Entwisle, S. W., Huang, H. Z., Kim, D., Yajima, M., Kaeberlein, M., & Villén, J.
ORCID
Venue
Nature Metabolism
Publisher
Springer Science and Business Media LLC
Published
2020-12-14
Volume
2
Issue
12
Pages
1472-1481
ISSN
2522-5812
DOI
10.1038/s42255-020-00319-x
PMC
PMC8017771
Cited by
45
References
5
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (F32 NS110109, R01 NS098329)
  • MEXT | Japan Society for the Promotion of Science (postdoctoral fellowship)
  • Uehara Memorial Foundation (postdoctoral fellowship)
  • U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (T32 LM012419)
  • U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (T32 HG00035)
  • Samuel and Althea Stroum Endowed Graduate Fellowships
  • U.S. Department of Health & Human Services | NIH | National Institute on Aging (P30 AG013280)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM119536)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review